Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $284,327 - $349,307
2,673 Added 900.0%
2,970 $385,000
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $284,327 - $349,307
-2,673 Reduced 90.0%
297 $385,000
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $170,893 - $228,541
2,970 New
2,970 $205,000
Q1 2020

May 08, 2020

SELL
$52.41 - $81.0 $51,885 - $80,190
-990 Closed
0 $0
Q3 2019

Oct 31, 2019

BUY
$61.55 - $75.43 $60,934 - $74,675
990 New
990 $218,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mogy Joel R Investment Counsel Inc Portfolio

Follow Mogy Joel R Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mogy Joel R Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mogy Joel R Investment Counsel Inc with notifications on news.